Peer Review History

Original SubmissionApril 24, 2020
Decision Letter - Rebecca A Krukowski, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-20-11106

Association between Behavioral Phenotypes and Response to a Physical Activity Intervention Using Gamification and Social Incentives: Secondary Analysis of the STEP UP Randomized Clinical Trial

PLOS ONE

Dear Dr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Rebecca A Krukowski

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1- Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Financial Disclosure section:

"This study was supported by Deloitte Consulting LLP and the University of Pennsylvania Health System through the Penn Medicine Nudge Unit. Funding was obtained by Mitesh Patel. The University of Pennsylvania conducted all analyses, and drafted and submitted the manuscript. The co-authors from the funding organization had the opportunity to review and provide comments on the manuscript. The University of Pennsylvania co-authors had full authority on whether or not to incorporate those comments. Deloitte was involved in study conceptualization but had no role in data collection and analysis, decision to publish, or preparation of the manuscript."

We note that one or more of the authors are employed by a commercial company: Deloitte Consulting.

2.2. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2.2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. 

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript presents a secondary analysis of data from a randomized clinical trial using latent class analysis to determine whether subgroups of participants responded different to the physical activity intervention. Overall, the methods and analytical approach are sound, and the results are interesting. The manuscript is well-written and succinct. I have a few recommendations for changes that I believe would further enhance the manuscript.

General comments:

1. I can appreciate that coming up with succinct, accurate names for each of the groups is a challenge. I thought the name for Class 2 was a good reflection of its defining characteristics. However, for Class 1 something that highlights their grit and conscientiousness might be more appropriate, as motivation was not directly assessed and extroversion was not as far above the mean as some of the other variables. For Class 3, again motivation was not assessed and the term “at-risk” is quite vague – at-risk for low physical activity? For poor mental health? I don’t have a suggestion for a perfect name for these groups, but I would encourage the authors to consider whether the current names can be improved.

2. I also appreciated that the authors did not overstate their findings and kept the discussion limited to this specific trial (e.g. p. 15, lines 294-6, “the ideal participant phenotype for a remotely monitored gamification intervention that uses behavioral economics and social influence to promote physical activity.”). On the other hand, this is a very specific intervention type, and readers may wonder whether these findings would be relevant to other types of behavioral interventions. Although there may be a limited number of studies that have used this exact approach (e.g., LCA in the context of physical activity RCTs), there are a variety of studies that have examined how subgroups of the total participant population respond differently to interventions. I would like to see the discussion incorporate some additional literature to put these results in the broader context of what we already know.

3. Similar to the comment above, I think it would be helpful to incorporate some additional discussion about how these types of studies can be used to enhance future interventions. The authors provide some general comments about targeting subgroups, but from a practical perspective, how might this be done? Based on this study and others like it, are there specific variables that should be consistently measured at baseline and used to determine what types of support participants may need? Are there evidence-based examples of different types of support being effective for subgroups of participants?

Specific comments:

p. 5, line 107: was the follow-up measure taken at the end of the 24-week intervention period? Were step counts averaged across a week at each time point?

p. 5, line 107-8: Did all participants wear the same wearable device? What device was it?

The manuscript sometimes uses “randomized clinical trial” and other times “randomized control trial” – be consistent throughout.

Reviewer #2: PONE-D-20-11106: statistical review

SUMMARY. This is a two-step secondary analysis of a previous clinical trial of daily changes of step counts (primary outcome). Subjects are first segmented according to three groups, using latent class methods. Then, generalized mixed-effects models are estimated to compare each intervention arm to control within each latent class for the intervention and follow-up periods. I have very little to say about this paper. Latent class analysis is correct and generalized linear mixed-effects models appropriately account for latent heterogeneity and longitudinal correlation of the outcomes. I just list below some minor points that the authors should address to improve clarity and reproducibility of the results.

MINOR POINTS

1. Table 2 is obtained by exploiting the conditional probabilities of the observed variables given the latent class: the table of these probabilities should be included in the paper, perhaps as supplementary material.

2. I guess that the mixed models that have been exploited are those of doi: 10.1001/jamainternmed.2019.3505. As a courtesy to the reader, please specify the kind of model you are using.

3. Please clarify that entropy (Table S1) is a measure of class separation and that, as such, it can be used for model selection.

4. Although data are available without restriction, they are not attached. Data should be inlcuded as supplementary material and metadata provided.

Reviewer #3: The aim of this secondary analysis of a remotely delivered randomized clinical physical activity promotion trial was to identify behavioral phenotypes and compare physical activity changes for each intervention arm relative to control within each behavioral phenotype. This study uniquely fills a gap in the physical activity promotion literature, helping advance our understanding of which gamification interventions – a promising and increasingly popular behavior change approach – may be most effective for different population subgroups. The identification and evaluation of behavioral phenotypes that are based on a combination of variables as opposed to a single variable is an insightful perspective rooted in a sound conceptual basis that has been successfully applied in other sectors. The large sample, consideration of variables relevant to physical activity that could be screened somewhat easily, and evaluation of physical activity change both at the end of the intervention and follow up are study strengths. The rationale for the analytic approach is well described, key limitations are highlighted, and reasonable interpretations of the findings are made. Some very minor concerns are listed below.

Minor Concerns

Introduction

• p. 3, line 60: Could you please clarify or provide a few examples in parentheses of what you mean by baseline participant traits to help differentiate from the variables you examined?

Methods

• Although it is mentioned in your main outcomes manuscript for the trial, could you please mention the wearable device that was used? Also, is it a wrist-worn device?

Discussion

• Your interpretations of your findings are logical. Nonetheless, are there any findings at all from previous physical activity promotion studies that could be discussed to help situate your findings in the broader literature – anything similar or different from your findings?

• It may not be a good idea to speculate too much, but do you have any thoughts about what could be explored in the future to help those who may have a more competitive orientation sustain their physical activity improvements? Or perhaps it could just be noted as a future area of inquiry if space permits.

• It may be worth mentioning that only daily step counts were examined – other outcomes may be of interest too and could be explored in future research (MVPA etc.).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We have included a point by point response to reviewer comments in this resubmission. The funding statement has also been revised to clarify the role of Deloitte and is included in our cover letter.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Rebecca A Krukowski, Editor

Association between Behavioral Phenotypes and Response to a Physical Activity Intervention Using Gamification and Social Incentives: Secondary Analysis of the STEP UP Randomized Clinical Trial

PONE-D-20-11106R1

Dear Dr. Chen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rebecca A Krukowski

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Rebecca A Krukowski, Editor

PONE-D-20-11106R1

Association between behavioral phenotypes and response to a physical activity intervention using gamification and social incentives: Secondary analysis of the STEP UP randomized clinical trial

Dear Dr. Chen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rebecca A Krukowski

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .